Pharmacovigilance
Pharmacovigilance Services
Powered by AI. Driven by Pharmacovigilance Expertise.
Advanced AI-powered automation across MICC, literature monitoring and safety database operations — reducing manual effort, accelerating workflows and enhancing operational efficiency.
- Typical timeline
- Ongoing service
- Clients served
- 800+
- Countries
- 64
Our Pharmacovigilance Services
Our Contract Research Organization (CRO) provides end-to-end pharmacovigilance (PV) services to ensure drug safety and regulatory compliance across the product lifecycle. From database setup and adverse event reporting to risk management and global submissions, we help pharmaceutical companies, biotech firms, and marketing authorization holders (MAHs) monitor and manage drug safety effectively. Our services are critical for maintaining patient safety, meeting stringent regulatory requirements, and supporting clinical and post-marketing phases for generics, biosimilars, and innovative drugs.
Our PV Expertise
AI-Powered PV System Setup
- End-to-end AI-enabled PV System Setup
- Intelligent Safety Database & Automated Data Extraction
- E2B R3 Regulatory Data Exchange
- System Configuration, Validation & Compliance
Medical Information Call Centre
Fully functional AI-powered 24×7 Medical Information Call Centre for continuous inquiry handling and adverse event information intake.
- 24/7 medical inquiry support
- Multilingual adverse event intake
- HCP & patient interaction
- Product complaint triage
PSMF & SOPs Preparation
- EMA/MHRA-compliant PSMF
- SOPs for PV activities
- Annexes & version control
- Quality system documentation
ICSR Case Processing
AI-based pharmacovigilance safety database with intelligent data extraction and coding capabilities, processing safety information directly from emails, PDFs, scanned documents and published literature.
- Triage & MedDRA coding
- E2B R2/R3 submissions
- Seriousness assessment
- Follow-up & reconciliation
Literature Monitoring
Fully automated AI-based literature monitoring system for continuous literature surveillance, intelligent article screening and identification of relevant safety information.
- GVP Module VI compliance
- Embase/PubMed searches
- ADR & signal screening
- Regulatory submissions
Aggregate Reports
- PSUR, PBRER, PADER
- DSUR & ASRs
- ICH E2C(R2) compliance
- Quality review & submission
Risk Management Plan
- EU-RMP & REMS preparation
- Safety specification
- Risk minimization measures
- RMP lifecycle management
Signal Management
- Disproportionality analysis
- Signal validation & assessment
- Empirica/VigiLyze tools
- Regulatory communication
QMS & Audit Support
- PV compliance monitoring
- Audit/inspection preparation
- CAPA management
- GVP & ICH E2E training
Global Submissions
- E2B-compliant submissions
- EMA, FDA, PMDA filings
- PvPI & WHO submissions
- PV gateway configuration
Medical Review
- ICSR & safety report review
- Benefit-risk assessments
- Signal trend analysis
- Medical narrative writing
PV Training
- GVP & ICH E2E training
- Train-the-trainer workshops
- Custom PV process design
Our PV Service Process
-
System Setup & Planning
We implement PV databases, PSMF, and SOPs tailored to your regulatory needs.
-
Data Collection & Monitoring
We handle ICSR processing, literature monitoring, and MICC operations for adverse event data.
-
Analysis & Reporting
We perform signal detection, prepare aggregate reports, and conduct benefit-risk evaluations.
-
Regulatory Submissions
We submit ICSRs, PSURs, and RMPs to global authorities like EMA, FDA, and PMDA.
-
Compliance & Audit Support
We ensure audit readiness, provide CAPA management, and offer ongoing PV training.
Compliance & Standards
Regulatory Bodies
- FDA (U.S. Food and Drug Administration)
- EMA (European Medicines Agency)
- ICH (International Council for Harmonisation)
- DCGI (Drugs Controller General of India)
- PMDA, Health Canada, TGA, WHO-UMC
Guidelines & Certifications
- GVP Modules (EMA)
- ICH E2A/E2B/E2C/E2E
- 21 CFR Part 11, EU Annex 11
- WHO TRS Annex 2–5
- PvPI (India)
Who it's for
- Pharmaceutical Manufacturing
- Biotechnology
- Generics & Biosimilars
- Marketing Authorization Holders
- Clinical Research
Why Choose Our PV Services?
Our CRO delivers comprehensive pharmacovigilance services to ensure drug safety and regulatory compliance. With expertise in ICSR processing, signal management, and global submissions, we help you meet stringent requirements from FDA, EMA, and other authorities. Partner with us to safeguard patients, streamline PV operations, and achieve regulatory success with confidence.
- Clients served
- 800+
- Countries
- 64
- Regulatory acceptance
- 100%
Frequently Asked Questions
What is a Pharmacovigilance Database? +
A PV database is a secure system used to collect, manage, and submit adverse event reports. It ensures regulatory compliance and accurate tracking of safety data across product lifecycles.
What services are included in a Medical Information Call Centre (MICC)? +
MICC services include responding to medical inquiries, product information dissemination, adverse event intake, and complaint logging—all handled by trained healthcare professionals.
What is the PSMF and why is it required? +
The Pharmacovigilance System Master File (PSMF) provides an overview of the PV system used by the Marketing Authorization Holder. It is a regulatory requirement in the EU and other markets.
What is ICSR and how do you process it? +
An Individual Case Safety Report (ICSR) is a detailed record of an adverse drug reaction. We handle collection, MedDRA coding, narrative writing, quality control, and submission to EudraVigilance, FDA FAERS, etc.
What is literature monitoring in PV? +
Literature monitoring involves scanning scientific journals and databases for reports of adverse events or new safety concerns related to your products. It's a mandatory pharmacovigilance activity.
What are PSUR, PBRER, and PADER reports? +
These are periodic safety reports required by regulatory bodies. PSUR (EU), PBRER (global format), and PADER (US FDA) summarize the benefit-risk balance of a product over a defined period.
Show all 14 questions
What is a Risk Management Plan (RMP)? +
An RMP outlines known and potential risks of a drug and describes how these will be minimized. It's essential for products with significant safety profiles or conditional approvals.
How do you manage safety signals? +
We follow a structured signal management process—detection, validation, prioritization, assessment, and recommendation—based on quantitative and qualitative safety data.
What does your pharmacovigilance database setup include? +
Our database setup includes implementation of validated safety databases like Argus Safety or Veeva Vault, workflow customization, MedDRA/WHO-DD coding, 21 CFR Part 11 compliance, and E2B R3 data exchange setup.
How does your Medical Information Call Centre operate? +
Our 24/7 MICC provides multilingual support for medical inquiries, adverse event intake, and product complaint triage, handling interactions from healthcare professionals and patients globally.
What is involved in ICSR case processing? +
ICSR processing includes triage, data entry, MedDRA coding, narrative writing, seriousness/causality assessment, and submission to authorities like EMA, FDA, and DCGI using E2B R2/R3 formats.
How do you ensure compliance with global PV regulations? +
We adhere to GVP Modules, ICH E2E, FDA 21 CFR Part 11, EU Annex 11, and regional requirements, with compliance monitoring, audit preparation, and CAPA management.
Who benefits from your pharmacovigilance services? +
Pharmaceutical companies, biotech firms, generic and biosimilar manufacturers, and MAHs benefit by ensuring drug safety, regulatory compliance, and effective risk management.
What is the role of literature monitoring in pharmacovigilance? +
Literature monitoring involves global and local surveillance for ADRs and safety signals using databases like Embase and PubMed, ensuring compliance with GVP Module VI.